Sanofi (SNYNF) Stock Price, News & Analysis

Company Overview

Sanofi is a France-based global biopharmaceutical company that researches, develops, manufactures and markets medicines and vaccines. Its portfolio focuses on immunology, rare diseases, vaccines, specialty care and established prescription medicines, serving patients and healthcare providers in markets around the world.

The company’s products include Dupixent for several inflammatory conditions, Beyfortus for the prevention of respiratory syncytial virus disease in infants, and vaccines for influenza, meningococcal disease, polio and other conditions. Sanofi also offers treatments across areas such as diabetes, cardiovascular disease, oncology and rare diseases.

Sanofi traces its roots to French pharmaceutical businesses established during the 20th century and became Sanofi-Aventis following the 2004 acquisition of Aventis. The company adopted the Sanofi name in 2011. Its global operations span research, manufacturing and commercial activities across North America, Europe, Asia and other international markets. Sanofi is led by Chief Executive Officer Paul Hudson.

Key Stats

• Today's Range: $80.00 to $82.14
• 50-Day Range: $77.48 to $93.45
• 52-Week Range: $77.08 to $106.34
• Volume: 645 shs
• Average Volume: 26,940 shs
• Market Capitalization: N/A
• P/E Ratio: 25.94
• Dividend Yield: 3.50%
• Price Target: N/A
• Consensus Rating: N/A

Sanofi Stock Analysis - MarketRank™

Sanofi scored higher than 31% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Sanofi.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Sanofi is 25.94, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 41.62.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sanofi is 25.94, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 202.38.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Sanofi has a short interest ratio ("days to cover") of 5.33.

Change versus previous month

Short interest in Sanofi has recently decreased by 28.63%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Sanofi is a leading dividend payer. It pays a dividend yield of 4.13%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Sanofi does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Sanofi is 90.78%. Payout ratios above 75% are not desirable because they may not be sustainable.

News and Social Media

• Score: 2.5 / 5
• News Sentiment: N/A

News Sentiment

Sanofi has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Sanofi this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sanofi insiders have not sold or bought any company stock.

Percentage Held by Institutions

30.06% of the stock of Sanofi is held by institutions.

Company Calendar

• Today: 10/12/2026
• Next Earnings (Estimated): 10/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:SNYNF
• CIK: 1121404
• Web: www.sanofi.com
• Phone: (315) 377-4000
• Fax: N/A
• Employees: 91,600
• Year Founded: 2004

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 25.94
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A